Br J Ophthalmol 1999;83:429-437 ( April )
Indocyanine green angiographic features prognostic of visual
outcome in the natural course of patients with age related macular
degeneration
Akira Obana,a
Yuko Gohto,a
Muneaki Matsumoto,a
Tokuhiko Miki,a
Kazuteru Nishigutib
a Department of
Ophthalmology, Osaka City University Medical School, b Department of Ophthalmology, Izumi City Hospital
Correspondence to: Akira Obana, MD, Department of Ophthalmology, Osaka City University
Medical School, Asahi-machi 1-4-3, Abeno-ku, Osaka 545-8585, Japan.
Accepted for publication 22 October 1998
 |
Abstract |
AIMS To determine
indocyanine green (ICG) angiographic features prognostic of visual
acuity loss in eyes following a natural course of exudative age related
macular degeneration (AMD).
METHODS 89 eyes of 72 patients (48 men, 24 women) aged between 50 and 87 years old (mean 69.5 (SD 8.8) years) with classic and/or occult choroidal neovascularisation
(CNV) were reviewed. ICG angiographic features were classified as
follows: type 1, well demarcated hyperfluorescence with late ICG
leakage; type 2, well demarcated hyperfluorescence with no late dye
leakage; type 3, poorly demarcated hyperfluorescence; type 4, no
hyperfluorescence. Follow up ranged from 6 to 67 months (mean 19.2 (11.5) months). Logistic regression analyses were performed using
change of visual acuity (worse or not) as the dependent variable, and
patient age, sex, characteristics of fluorescein angiography (classic
or occult CNV), location of CNV, and each ICG type as the independent
variables. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
RESULTS Type 1 CNV was
associated with the highest risk for visual acuity loss (OR: 7.50, CI:
1.42-39.55, p=0.018) among the present variables. In contrast, CNV
having no ICG leakage (type 2, 3, and 4), represented no significantly
increased risk.
CONCLUSION Well
demarcated hyperfluorescence with late ICG leakage appears to be
predictive of visual acuity loss in eyes with CNV. Thus, ICG
angiography may offer a useful means of predicting visual outcomes in AMD.
(Br J Ophthalmol 1999;83:429-437)
 |
Introduction |
The principal mechanism for severe visual loss in
exudative age related macular degeneration (AMD) is choroidal
neovascularisation (CNV) and its sequelae exudation, haemorrhage,
fibrovascular proliferation, and disciform scarring. Hayashi
et al 1 were the first to
report that CNV showed hyperfluorescent leakage in the late phase of indocyanine green (ICG) angiography, and recently, ICG angiography has
been demonstrated to be useful in detecting CNV, especially when
fluorescein angiography (FAG) cannot reveal well defined CNV. Yannuzzi
et al 2 and Slakter
et al 3 found that 39% and
44%, respectively, of patients with occult CNV by FAG showed well
demarcated hyperfluorescence by ICG angiography. However, ICG
appearances of CNV vary. For example, Avvad et
al 4 observed three different ICG hyperfluorescent
patterns in classic CNV by FAG: early well demarcated, late well
demarcated, and late poorly demarcated hyperfluorescence. It has been
suggested that these various ICG appearances correlate with the
different characteristics of specific CNV, and some attempts have been
made to demonstrate such correlations between ICG angiographic features
and histological characteristics.5-8 Chang
et al 5 demonstrated that
subretinal pigment epithelial CNV showed late, well demarcated
hyperfluorescence with little dye leakage on ICG angiography, and
suggested that this type of lesion was clinically inactive and did not
cause severe visual acuity loss. Chang et
al 5 and Trabucchi et
al 6 reported that subretinal fibrous scars showed
early hypofluorescence and late, poorly delineated areas, or late
staining of the proliferative tissue on ICG angiography. Nakajima
et al 7 classified CNV into
four types on the basis of ICG angiography (type 1, hyperfluorescence in both the early and late phase; type 2, hyperfluorescence only in the
early phase; type 3, hyperfluorescence in the late phase; type 4, virtually no hyperfluorescence in any phase), and examined histological features of surgically removed CNV. Finding that type
1 CNV had many vascular channels and was not covered with the retinal
pigment epithelium (RPE) and that type 4 had abundant fibrous tissue,
they concluded that ICG appearance correlated with histological characteristics.
If different ICG angiographic features are correlated with
different CNV histological characteristics and activities, it seems reasonable to hypothesise that eyes with different ICG angiographic features have different natural courses. If so, is it possible to
determine which, if any, ICG angiographic features can identify eyes at
high risk for visual loss?
Guyer et al 9 classified the
appearance of ICG angiography of CNV into three groups based on the
size of the hyperfluorescent lesion focal spots, plaque, and a
combination of both, and investigated the natural course of each type.
However, because the number of eyes with each CNV type they studied was
relatively small, their findings were inconclusive. We classified our
cases in the same way but found no significant difference in visual
prognosis among these groups.10 Thus, we concluded that
classification based on the size of hyperfluorescence is not helpful in
determining visual prognosis.
Our clinical experience
suggested two types of late hyperfluorescence: hyperfluorescence which,
in contrast with surrounding fluorescence levels, increased in the late
phase, suggesting late ICG leakage, and hyperfluorescence the
brightness of which diminished in the late phase. Also, we noted that
eyes with CNV showing hyperfluorescence with marked ICG dye leakage in
the late phase often had subretinal bleeding or progressed to the
disciform stage, with severe visual acuity loss. In contrast, as shown
by Chang et al,5 eyes with CNV
showing hyperfluorescence without marked dye leakage on ICG angiography
preserved good visual acuity. Therefore, we classified ICG features of
CNV on the basis of borders of hyperfluorescence and the presence of
dye leakage, and investigated the visual acuity outcomes associated
with each type to CNV in an attempt to determine ICG angiographic
features that might identify eyes at high risk for visual loss.
 |
Patients and methods |
PATIENT RECRUITMENT
We reviewed the records and photographs of 262 eyes of 220 patients (145 men, 75 women) who had been diagnosed with AMD and examined by FAG and ICG angiography in Osaka City University Hospital between November 1991 and March 1997. Among these patients, 37 eyes had
no evidence of CNV on FAG, and they were excluded from the present
study. Also excluded were 12 eyes that had had previous laser
treatment, 98 eyes that had had laser treatment during the follow up
period, four eyes that had undergone surgery to remove CNV, six eyes
which, upon a review of the records and photographs, showed that the
diagnosis should have been idiopathic CNV or high myopia, nine eyes
with a follow up of less than 6 months, four eyes with other disorders
affecting visual acuity such as glaucoma and diabetic retinopathy, and
three eyes in which slit lamp examination showed that cataract had
developed during the follow up period.11 The remaining 89 eyes of 72 patients (48 men, 24 women) who satisfied the criteria shown
in Table 1 were entered in the present study. The patients' ages
ranged from 50 to 87 years old (average 69.5 (SD 8.8) years). Forty
seven eyes were right and 42 left. Follow up ranged from 6 to 67 months
(mean 19.2 (11.5) months). The patients underwent best corrected visual
acuity measurement by a lantern type visual acuity test chart (with
results recorded in decimal notation), indirect ophthalmoscopic
observation, and biomicroscopy using a Goldmann contact lens. FAG and
ICG angiographies were taken using a fundus camera (Topcon IMAGEnet
H-1024 Digital Imaging System, Topcon, Tokyo). For ICG angiography, 25 or 50 mg of ICG was dissolved in 2 ml of aqueous solution and injected
intravenously. ICG angiography was performed in accordance with the
standards of the ethics committee of Osaka City University Medical
School and signed informed consent was obtained. We included patients demonstrating classic CNV or occult CNV by FAG.11 For
purposes of further statistical analysis, eyes with a combination of
classic and occult CNV were classified as having occult CNV. The
location of CNV was designated as subfoveal, juxtafoveal, and
extrafoveal based on the Macular Photocoagulation Study Group (MPS)
definition.12
CLASSIFICATION OF ICG ANGIOGRAM
We observed ICG angiographic features of the exact lesions in
which classic or occult CNV had been confirmed on FAG. The ICG features
were judged at three different phases; within 3 minutes after ICG
injection (early phase), 5-10 minutes after injection (middle phase),
and more than 20 minutes after injection (late phase). The ICG features
of the presumed CNV were classified into four groups:
type 1: well demarcated
hyperfluorescence with ICG dye leakage occurring in the late phase from
the whole lesion or a part of the lesion. There were two patterns of
hyperfluorescence: one was well demarcated hyperfluorescence and/or
cartwheel of capillary vessels in the early phase and lasting
throughout the late phase with late ICG leakage (Fig 1), and the other
was hyperfluorescence obscured in the early phase but becoming well
demarcated in the middle to late phase with late ICG leakage (Fig 2);
type 2: well demarcated
hyperfluorescence in the early and middle phase with little ICG leakage
in the late phase (Figs 3, 4); type 3: poorly demarcated hyperfluorescence in any phase (Fig 5);
type 4: no hyperfluorescence in any
phase (Fig 6).


View larger version (254K):
[in this window]
[in a new window]
|
Figure 1
Right eye of a 67 year old man. (A) Fundus
photograph shows haemorrhagic pigment epithelial detachment with serous
sensory retinal detachment. Visual acuity was 20/30. (B) Fluorescein
angiography 5 minutes after dye injection shows hyperfluorescence of
occult choroidal neovascularisation and pooling of the dye in the
subretinal pigment epithelial space. (C) Early phase indocyanine green
angiography shows well demarcated hyperfluorescence of choroidal
neovascularisation (surrounded by arrowheads). (D) Late phase
indocyanine green angiography. The contrast between the fluorescence of
the neovascular tissue and that of the surrounding area is high, and
hyperfluorescence is slightly greater, with a blurred margin, in the
late phase than that in the early phase. Dye pooling in the subretinal
pigment epithelial space is noted. (E) Fundus photograph taken 19 months later shows a disciform lesion with subretinal haemorrhage and
exudate. His visual acuity had declined to 20/2000.
|
|


View larger version (303K):
[in this window]
[in a new window]
|
Figure 2
Left eye of a 70 year old woman. (A) Fundus
photograph shows elevation of retinal pigment epithelium with
subretinal haemorrhage and sensory retinal detachment. Visual acuity
was 20/30. (B) Fluorescein angiography 7 minutes after dye injection
shows fluorescein leakage from the choroidal neovascularisation. Blood
blocks a part of hyperfluorescence from the neovascularisation. (C)
Early phase indocyanine green angiography shows hyperfluorescence
(arrow). (D) Late phase indocyanine green angiography shows
hyperfluorescent plaque of choroidal neovascularisation (surrounded by
arrowheads). Dye leakage overlying the plaque is noted at three
portions (arrows). Upper part of the plaque is obscure in early phase.
(E) Fundus photograph taken 10 months later shows progression of the
subretinal fibrous tissue corresponding to the hyperfluorescent area in
(D). Her visual acuity had declined to 20/70.
|
|

View larger version (154K):
[in this window]
[in a new window]
|
Figure 3
Right eye of a 58 year old man. Visual acuity was
20/400. (A) Fundus photograph shows subretinal fibrovascular tissue
with surrounding subretinal haemorrhage. (B) Fluorescein angiography 34 seconds after dye injection shows hyperfluorescence from the choroidal
neovascularisation. (C) Early phase indocyanine green angiography shows
well demarcated hyperfluorescence (surrounded by arrowheads). (D) Late
phase indocyanine green angiography. The lesion shows little ICG
leakage. Follow up of 34 months revealed that exudative change such as
subretinal haemorrhage and sensory retinal detachment had resolved,
leaving a subretinal fibrous scar; visual acuity was preserved.
|
|

View larger version (136K):
[in this window]
[in a new window]
|
Figure 4
Left eye of a 71 year old man. (A) Fundus photograph
shows elevation of retinal pigment epithelium with a little sensory
retinal detachment and hyperpigmentation or hypopigmentation associated
with drusen. Visual acuity was 20/30. (B) Fluorescein angiography 7 minutes after dye injection shows mild dye leakage. (C) Middle phase
indocyanine green angiography shows slight hyperfluorescence
(surrounded by arrowheads). (D) Late phase indocyanine green
angiography shows well demarcated choroidal hyperfluorescence. Since
the margin of hyperfluorescence is clear and the size of the
hyperfluorescence in the late phase is same to that in the middle
phases, we assumed that there was no active dye leakage. The eye had no
apparent morphological change during a 31 month follow up period and no
loss of vision.
|
|

View larger version (108K):
[in this window]
[in a new window]
|
Figure 5
Left eye of a 61 year old woman. Visual acuity
was 20/30. (A) Fundus photograph shows mottled pigmentation of retinal
pigment epithelium and drusen with sensory retinal detachment. (B)
Fluorescein angiography 6 minutes after dye injection shows dye leakage
form choroidal neovascularisation. (C) Late phase indocyanine green
angiography. Hyperfluorescence is apparent, but the border is not
distinct. Sensory retinal detachment was resolved at the 21 months'
follow up examination, at which time her visual acuity had improved to
20/20.
|
|

View larger version (147K):
[in this window]
[in a new window]
|
Figure 6
Right eye of a 72 year old man. Visual acuity was
20/200. (A) Fundus photograph shows subretinal fibrous tissue with
surrounding subretinal haemorrhage. (B) Fluorescein angiography 1 minutes after dye injection shows hyperfluorescence of the subretinal
fibrovascular tissue. (C) Early phase indocyanine green angiography.
The fluorescence of the subretinal fibrovascular tissue (arrow) is
weaker than that of the surrounding chorioretina. (D) Late phase
indocyanine green angiography shows no apparent hyperfluorescent lesion
corresponding to the subretinal fibrovascular tissue.
|
|
A lesion was designated hyperfluorescent if the hyperfluorescence could
be distinguished from that of the surrounding area. A lesion with the
same brightness of fluorescence or hypofluorescence compared with the
surrounding region was defined as having no hyperfluorescence. Well
demarcated hyperfluorescent lesions were defined as those with borders
readily distinguishable from the surrounding level of fluorescence,
whereas poorly demarcated lesions had borders that were difficult to
distinguish in this way. When both types of borders were present in one
lesion, the image was classified as having a poorly demarcated
hyperfluorescence. ICG dye leakage was said to be present when the
following three criteria were met: (1) the contrast of fluorescence
between the CNV and the surrounding fluorescence level markedly
increased in the late phase, (2) the size of the hyperfluorescent
lesion became larger in the late phase than that it had been in the
early and middle phases, and (3) the borders of hyperfluorescence
became blurred in the late phase. FAG and ICG angiograms were
analysed independently by two of the authors (OA and NK). If there was
a discrepancy, the reclassification was performed together by both authors.
STATISTICAL ANALYSIS
Decimal visual acuity was converted to the minimal angle of
resolution (MAR), and the logarithm of MAR was used to calculate average of visual acuity. The change in visual acuity was categorised as either worse or not. "Worse" visual acuity was defined as a change of two or more folds of MAR. Logistic regression analyses were
performed using the SAS system (SAS Institute, Cary, NC, USA), with the change of visual acuity (worse or not) as the dependent variable, and patient age, sex, characteristics of FAG (classic type of
CNV or occult type), location of CNV (extrafoveal, juxtafoveal, or
subfoveal), and ICG angiographic features (presence of type 1, 2, or 3)
as the independent variables. Since the absence of type 1, 2, or 3 represented type 4, type 4 was not considered an independent variable.
Age was used as a continuous variable, and the other factors as
categorical variables. Odds ratios (ORs) and 95% confidence intervals
(CIs) were calculated to assess the relative risk of visual acuity loss.
 |
Results |
Initial visual acuity in the 89 study eyes ranged from 20/13 to
counting fingers; the geometric mean visual acuity was 20/77. Visual
acuity at the final follow up examination ranged from 20/17 to hand
movements; the geometric mean was 20/125. Thirty one eyes (34.8%) had
a visual acuity loss of two or more folds of MAR. Seven eyes (7.9%)
improved by one half or less folds of MAR; 51 eyes (57.3%) had no
change in visual acuity. Twenty eight eyes (31.4%) had classic CNV by
FAG, 58 (65.2%) had occult CNV. Three (3.4%) had a combination of
classic and occult CNV. Sixteen eyes (18.0%) had extrafoveal CNV, 23 (25.8%) juxtafoveal, and 50 (56.2%) subfoveal CNV. Thirty four
(38.2%) showed type 1 CNV on ICG angiography, 33 (37.1%) type 2, six
(6.7%) type 3, and 16 (18.0%) type 4. Visual acuity outcomes and CNV
characteristics by sex and age are summarised in Table 2, and ORs with
95% CI and their p values for each variable are shown in Table 3. The
risk for visual acuity loss increased with age (OR: 1.20, p=0.0001). OR
was 6.19 when each patient was compared with another patient 10 years
older. The increased risk for visual acuity loss was also significantly
higher in men than in women (OR: 4.30, p=0.035). The location of the
CNV did not affect the significant change of visual acuity. Occult CNV
on FAG showed a moderate but non-significant increase in the risk of
visual acuity loss. Among ICG features of CNV, type 1 showed significantly high increased risk (OR: 7.50, p=0.018).
 |
Discussion |
In the present study, CNV showing well demarcated
hyperfluorescence with dye leakage in the late phase (type 1) was
associated with the highest risk for visual acuity loss among the
dependent variables investigated (OR: 7.50, CI: 1.42-39.55, p=0.018).
In contrast, CNV showing well demarcated hyperfluorescence but having no ICG leakage (type 2) represented no significant increased risk (OR:
1.30, CI: 0.24-6.91, p=0.759). Thus, late ICG leakage from CNV was
associated with loss of visual acuity during follow up (mean 19.2 (11.5) months).
Approximately 98% of the ICG binds to protein.13 14 Free
ICG molecules are presumed to penetrate the normal fenestration and
intercellular junctions of the choriocapillaris, while protein bound
ICG molecules barely penetrate at all. Therefore, it is speculated that
ICG leakage results from a breakdown of the intercellular junction of
the endothelial cells of CNV or increased permeability of the
fenestration of CNV, although no difference between the permeability of
the two types of fenestration that is, normal fenestration of the
choriocapillaris and fenestration of CNV, has been reported. Ishibashi
et al's failure to find intercellular junctional complexes among the endothelial cells of immature active CNV,15 suggests that it is in this type of CNV that ICG
leakage occurs. On the other hand, Ryan et
al 16 found that fluorescein leakage occurred when
the CNV was not covered by the RPE and there was subretinal fluid space
around the CNV. This phenomenon has not been investigated in ICG
angiography, but the same mechanism is likely. Some space may be
necessary to allow leaked ICG molecules to pool around the CNV. We
speculate, then, that the CNV that showed ICG leakage (type 1) was an
immature, active CNV, or CNV not entirely covered by RPE. This
conjecture is consistent with Nakajima et
al's7 report that CNV that showed early and late well demarcated hyperfluorescence were highly vasculative, containing immature new vessels, and was not covered by RPE. Our investigation of
the reason for visual acuity loss in eyes with type 1 CNV showed that
among 19 eyes with visual acuity loss, seven had visual loss due to
enlargement and extension of subretinal fibrous tissue to the fovea,
four due to the presence or increase of subretinal haemorrhage, one due
to occurrence of vitreous haemorrhage, three due to long standing
presence of sensory retinal detachment, and four due to the enlargement
and extension of retinal pigment epithelial degeneration to the fovea.
Therefore, immature, active type 1 CNV apparently grows or occurs
bleeding, reducing visual acuity.
Two patterns of type 2 CNV were apparent in the present study. One had
subretinal fibrovascular tissue, which showed a relatively small amount
of fluorescein leakage (Fig 3). Jalkh et
al 17 have suggested that this type of CNV is
inactive. The other pattern was similar to the ICG appearance of the
right eye in a case reported by Chang et
al.5 Since the absorption and emission wavelength of ICG is in the infrared range, which readily penetrates the RPE,
subretinal pigment epithelium CNV are also well delineated by ICG
angiography. Thus, CNV are well delineated in the early phase, but as
shown by Chang et al,5 there
may be little leakage from CNV buried in the basal laminar deposits
with no space around the CNV. We speculated that the late
hyperfluorescence of this type of CNV (Fig 4) represented staining of
some materials such as basal laminar and basal linear deposits just
around the CNV.
We did not find any distinct reason why type 3 in the present study did
not represent a high risk for visual acuity, but some cases seemed to
have a subretinal pigment epithelium CNV similar to that in type 2.
Eyes with type 4 CNV in the present study had subretinal fibrous
tissue, which was similar to the ICG appearance reported by Chang
et al 5 and Trabucchi
et al.6 This type of CNV reportedly showed fibrous reaction, and Trabucchi
et al demonstrated that the endothelium of
the new vessels had a non-leaking morphology, with tight intercellular
junctions and no fenestration.
The prognosis of visual acuity in the eyes that had CNV showing no late
ICG leakage (type 2, 3, or 4) over a period longer than the present
follow up is unknown. Since active CNV may develop from the
hyperfluorescent lesions in these eyes, we will continue to follow them carefully.
The MPS18-20 reports noted that visual acuity loss was
more frequently in older individuals who had classic CNV. Consistent with these previous studies, we found that increased risk for visual
acuity loss was significantly higher in older patients, although our
cases included occult CNV. On the other hand, our findings that eyes
with occult CNV had a higher risk for visual acuity loss than those
with classic CNV conflicts with the finding in other
studies21 22 that the natural history of the occult type
was more benign than that of the classic type. However, our finding may
be unreliable, since the OR of this type of CNV by FAG in the present
study was statistically non-significant. Also, the relatively small
number of eyes studied may have introduced some bias.
In the present study, visual acuity loss occurred in five of 16 (31%)
eyes with extrafoveal CNV, six of 23 (26%) with juxtafoveal CNV, and
20 of 50 (40%) with subfoveal CNV. Subfoveal CNV tended to have a high
rate of visual acuity loss, but the difference between the incidence of
visual acuity loss in each location was non-significant, and the
location of CNV had no significant effect on the relative risk of
visual acuity loss among the dependent variables we investigated. These
findings are consistent with the MPS18-20 finding that
although visual acuity loss occurred more frequently in eyes with
subfoveal CNV than in those with extrafoveal CNV, the difference was
non-significant.
According to the MPS data,18-20 men with juxtafoveal or
subfoveal classic CNV have a higher rate of visual acuity loss than women. Bressler et al 23 also
suggest that men with occult CNV have a higher frequency of visual
acuity loss than women. Our results are consistent with these findings.
In the present study, late ICG leakage was evaluated by two of the
authors (OA and NK), who looked for the criteria delineated in our ICG
classification. While suitable for a clinical setting, this method of
quantifying the amount of ICG leakage is still necessarily subjective
to a degree. We are investigating a new, presumably more objective,
method of computer assisted measurement of leaked ICG fluorescence.
The number of patients in the present study was small; however, it
appears that there are substantial differences in the visual acuity
outcome of patients with CNV, depending on ICG angiographic features.
Since, however, many factors, such as smoking, systemic hypertension,
dietary nutrition, exposure to light, and genetic predisposition,
affect the development of CNV,24 25 and these factors may
influence the prognosis once CNV has developed, it is difficult to
predict visual acuity outcomes precisely. Still, ICG angiography seems
to offer useful information in this respect.
 |
Acknowledgments |
The authors acknowledge the statistical assistance of Mitsuru
Fukui, PhD, in the Department of Statistics, Osaka City University Medical School.
This study was supported by a grant in aid for scientific research C2
of the Ministry of Education, Science, Sports and Culture, Japan (No 09671812).
 |
References |
| 1.
|
Hayashi K,
de Laey JJ. Indocyanine green angiography of choroidal neovascular membranes.
Ophthalmologica
1985;190:30-39[Medline].
|
| 2.
|
Yannuzzi LA,
Slakter JS,
Sorenson JA,
et al. Digital indocyanine green videoangiography and choroidal neovascularization.
Retina
1992;12:191-223[Medline].
|
| 3.
|
Slakter JS,
Yannuzzi LA,
Sorenson JA,
et al. A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration.
Arch Ophthalmol
1994;112:465-472[Abstract].
|
| 4.
|
Avvad FK,
Duker JS,
Reichel E,
et al. The digital indocyanine green videoangiography characteristics of well-defined choroidal neovascularization.
Ophthalmology
1995;102:401-405[Medline].
|
| 5.
|
Chang TS,
Freund KB,
Cruz ZDL,
et al. Clinicopathologic correlation of choroidal neovascularization demonstrated by indocyanine green angiography in a patients with retention of good vision for almost four years.
Retina
1994;14:114-124[Medline].
|
| 6.
|
Trabucchi G,
Brancato R,
Molfetta VD,
et al. Indocyanine green and fluorescein angiography of surgically excised macular choroidal neovascularizations: correlations with histopathologic and ultrastructural findings.
Graefes Arch Clin Exp Ophthalmol
1996;234:294-299[Medline].
|
| 7.
|
Nakajima M,
Shimada H,
Sato M,
et al. Comparison between indocyanine green angiography and histopathological observations of choroidal neovascular membrane in age-related macular degeneration.
J Jpn Ophthalmol Soc
1997;101:584-592.
|
| 8.
|
Lee BL,
Lim JI,
Grossniklaus HE. Clinicopathologic features of indocyanine green angiography-imaged, surgically excised choroidal neovascular membranes.
Retina
1996;16:649.
|
| 9.
|
Guyer DR,
Yannuzzi LA,
Slakter JS,
et al. Classification of choroidal neovascularization by digital indocyanine green videoangiography.
Ophthalmology
1996;103:2054-2060[Medline].
|
| 10.
|
Nishiguchi K,
Obana A,
Gohto Y,
et al. Classification and visual outcome of choroidal neovascularization in age-related macular degeneration by indocyanine green angiography.
Jpn J Clin Ophthalmol
1998;52:1131-1134.
|
| 11.
|
Emery JM,
Little JH.
Phacoemulsification and aspiration of cataract: surgical techniques, complications and results. St Louis: CV Mosby, 1979;45-48.
|
| 12.
|
Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study.
Arch Ophthalmol
1991;109:1242-1257[Abstract].
|
| 13.
|
Cherrick GR,
Stein SW,
Leevy CM,
et al. Indocyanine green observations on its physical properties, plasma decay, and hepatic extraction.
J Clin Invest
1960;39:592-600.
|
| 14.
|
Saito T,
Komatsu Y,
Mori S,
et al. A study of serum protein fraction binding to indocyanine green (ICG) by combined method of immunoelectrophoresis and ICG fundus videosystem.
J Jpn Ophthalmol Soc
1996;100:617-623.
|
| 15.
|
Ishibashi T,
Miller H,
Orr G,
et al. Morphologic observations on experimental subretinal neovascularization in the monkey.
Invest Ophthalmol Vis Sci
1987;28:1116-1130[Abstract/Free Full Text].
|
| 16.
|
Ryan SJ,
Stout JT,
Dugel PU. Subretinal neovascularization.
In:
Ryan SJ,
ed.
Retina. St Louis: CV Mosby, 1994;1027-1047.
|
| 17.
|
Jalkh AE,
Nasrallah FP,
Marineli I,
et al. Inactive subretinal neovascularization in age-related macular degeneration.
Ophthalmology
1990;97:1614-1619[Medline].
|
| 18.
|
Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial.
Arch Ophthalmol
1982;100:912-918[Abstract].
|
| 19.
|
Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial.
Arch Ophthalmol
1990;108:816-824[Abstract].
|
| 20.
|
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial.
Arch Ophthalmol
1991;109:1220-1231[Abstract].
|
| 21.
|
Macular Photocoagulation Study Group. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration.
Arch Ophthalmol
1996;114:400-412[Abstract].
|
| 22.
|
Stevens TS,
Bressler NM,
Maguire MG,
et al. Occult choroidal neovascularization in age-related macular degeneration. A natural history study.
Arch Ophthalmol
1997;115:345-350[Abstract].
|
| 23.
|
Bressler NM,
Frost LA,
Bressler SB,
et al. Natural course of poorly defined choroidal neovascularization associated with macular degeneration.
Arch Ophthalmol
1988;106:1537-1542[Abstract].
|
| 24.
|
Vingerling JR,
Hofman A,
Grobbee DE,
et al. Age-related macular degeneration and smoking. The Rotterdam Study.
Arch Ophthalmol
1996;114:1193-1196[Abstract].
|
| 25.
|
Elman MJ,
Fine SL. Exudative age-related macular degeneration.
In:
Ryan SJ,
ed.
Retina. St Louis: CV Mosby, 1994;1103-1142.
|
© 1999 by British Journal of Ophthalmology
|
|